BioNTech opened the first vaccine factory in Africa

9.01.2024 16:15:48

German biotechnology company BioNTech opened its first vaccine factory in Africa in Kigali, the capital of Rwanda. The factory, which consists of containers called "BioNTainer" and whose construction started in 2022, will produce mRNA-based vaccines for African countries. Rwandan President Paul Kagame, BioNTech's CEO and co-founder Prof. attended the opening of the factory. Dr. Uğur Şahin and guests attended. President Kagame emphasized that a vaccine production facility was established in Africa in a short time, although it was said that it would take 30 years. The facility, which will start operating at full capacity in 2025, is planned to produce up to 50 million doses of vaccine annually. According to African Development Bank data, continental countries import 70 percent of the medicines they need and produce only 1 percent of vaccines. The production facility, whose foundation was laid in June 2022, will facilitate faster access of African countries to mRNA vaccines.